Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD

Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD

News Highlights

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 11, 2021 (News) — Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer, announced that its T-SPOT®.COVID test will be used for T cell testing in the COV-AD (COVID infection in patients with Antibody Deficiency) study in collaboration with the University of Birmingham. The study will monitor the clinical course of SARS-CoV-2 infection and the immunological response of patients to vaccination. The study will collect samples from 13 sites around the UK.

The COV-AD study aims to build on the UK Primary Immunodeficiency Network (UKPIN) data by determining the prevalence, course and outcomes of SARS-CoV-2 infection in patients with Primary Antibody Deficiency (PAD)/Secondary Antibody Deficiency (SAD). This study should lead to a clearer understanding of whether individuals with antibody deficiency mount durable immune responses, and if they do not, the impact that has on the virus itself. Development of anti-SARS-CoV-2 immunity to COVID infection or vaccination will be tested by blood sampling to measure specific antibody titre and for the presence of anti-SARS-CoV-2 T cells. The results of this study will be widely applicable to immunosuppressed patients, development of vaccination strategies and the understanding of risk for continuous virus transmission.

Oxford Immunotec’s T-SPOT.COVID kit is CE marked for IVD use and will be used to assess the T cell response in patients following SARS-CoV-2 infection or vaccination. The kit uses the T-SPOT technology platform, a commercialized, modified ELISPOT platform, which allows for the standardized and reproducible measurement of T cells reactive to SARS-CoV-2. The T-SPOT technology has previously been used in TB testing (the T-SPOT.TB test) where it is known to maintain its high performance even in immunosuppressed individuals. PAD/SAD are a diverse group of disorders, characterised by various degrees of dysfunctional antibody production. Understanding the T cell response to infection or vaccination in study subjects is therefore of critical importance to determining if the immune system is responding in these individuals at all. It could also help to increase the understanding of the role T cells play in combating COVID-19 in the general population.

Chief Investigator of COV-AD Professor Alex Richter, of the University of Birmingham, said: “Nationally, a number of patients with immunodeficiency have had severe or prolonged illness with COVID-19. Understanding why some patients do well and others do not, is so important. Being unable to clear the virus is not just a problem to the patient but is potentially a public health problem too.”

Dr. Andrew Makin, VP of Medical Affairs at Oxford Immunotec stated; “We are pleased to be partnering with the University of Birmingham on this clinical trial which will help characterize COVID-19 infection in patients with antibody deficiency. Measuring the T cell response in immune deficient patients will allow for a more comprehensive understanding of the immune response and inform on the vital role T cells may play in SARS-CoV-2 infection.”

For further information visit www.tspotcovid.com.

About Oxford ImmunotecOxford Immunotec is a global, high-growth diagnostics company and part of the PerkinElmer group. We bring energy and invention to a world in need of diagnostic truth. We are uniquely placed as the only company in the world offering regulated ELISPOT assays for T cell measurement, with approval around the globe. Our leading product, the T-SPOT.TB test, is used for diagnosing infection with Tuberculosis, the world’s largest cause of death from infectious disease. The Company is an experienced manufacturer of IVD tests, operating under a fully audited Quality Management System, ensuring rigorous batch control. The company has manufactured in excess of 20 million clinical T cell tests for TB infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States (where it has received pre-market approval from the Food and Drug Administration), Europe (where it has obtained a CE mark), as well as Japan and China. The recently released T-SPOT.COVID test is CE marked in Europe for clinical use to understand the T cell immune response to SARS-CoV-2 infection and has been submitted to the FDA for emergency use authorization in the US (www.tspotcovid.com). The Company is headquartered near Oxford, U.K. and in Marlborough, MA. Additional information can be found at www.oxfordimmunotec.com.

About PerkinElmerPerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

About the University of BirminghamThe University of Birmingham is ranked amongst the world’s top 100 institutions, and its work brings people from across the world to Birmingham, including researchers and teachers and more than 6,500 international students from nearly 150 countries. www.birmingham.ac.uk

For Media Inquiries: US: Mary ConwayMKC Strategies, LLCTel: +1 (516) 606-6545 MConway@MKCStrategies.com

For Media Inquiries: Megan AndersonZPB AssociatesMobile: 07597572287Office: (020) 7018 1124megan.anderson@zpb-associates.com

 

  • Check the latest Health news updates and information.
  • Please share this news Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD with your friends and family to support us your one share helps us a lot.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
On June 21, Cyberpunk 2077 will be available on the PlayStation Store

On June 21, Cyberpunk 2077 will be available on the PlayStation Store

Sony likely also responded so swiftly and harshly against CD Projekt Red because the studio told customers to ask PlayStation for refunds — this put a ...
Time Finance See Adjusted Profit FY 2021;  Establish strategic goals

Time Finance See Adjusted Profit FY 2021; Establish strategic goals

Source www.marketwatch.com Write to Adria Calatayud at adria.calatayud@dowjones.com The company said its net lending book as of May 31 was around GBP98.8 ...
According to Microsoft, Xbox One users will be able to play next-generation games over the cloud

According to Microsoft, Xbox One users will be able to play next-generation games over the cloud

However, in a blog post published on Xbox Wire, Microsoft revealed its plans to provide Xbox One users access to those next-gen titles via cloud gaming. ...
Google Gives Green Flag for Release of its Dark Mode Feature

The Google Photos Locked Folder is now available for Pixel users

Locked Folder for Google Photos now rolling out for some Pixel users As the name suggests, Locked Folder lets you securely hide your sensitive photos or ...
MacRumors had a look at watchOS 8

Apple Watch Series 7 Is Supposed to Include Body Temperature and Blood Sugar Sensors

The Cupertino, California-based tech giant is planning to refresh the line this year – with a model likely dubbed the Apple Watch Series 7 – by adding a ...
Pluralsight Appoints Mark Miller Chief Financial Officer

Pluralsight Appoints Mark Miller Chief Financial Officer

Media Contact Pluralsight is the leading technology workforce development company that helps companies and teams build better products by developing critical ...
MacRumors had a look at watchOS 8

With NightWatch, you can turn your Apple Watch into a cool bedside orb

Bedroom black watch 1296x 0 png Set to release later this month, NightWatch is a combination charging dock, magnifying glass, and acoustic amplifier, the ...
Trouble Trading for Beginners, Cubs Make Money, Value of Depth Players, More

Trouble Trading for Beginners, Cubs Make Money, Value of Depth Players, More

We’ve already discussed Kyle Gibson – in terms of someone who can eat innings this and next season (and be acquired at a relatively low cost), I think he’s ...
Record Rise in US Wholesale Prices Last Year – Finance and Trade

Record Rise in US Wholesale Prices Last Year – Finance and Trade

Analysts said that the big jump in wholesale prices following the sizable gain in consumer prices underscores the current upward movement in inflation. Last ...
Lankford Joins Group of Senators Requesting Documents on Pandemic Control by Health Agencies |  News

Lankford Joins Group of Senators Requesting Documents on Pandemic Control by Health Agencies | News

Source “It is unclear the extent to which NIH officials, including Dr. Fauci, considered the possibility that the virus originated in a laboratory and what, ...
Show next
Compsmag - Latest News from tech, business and health
Logo